Novartis Ag (NVS) Amortization (2009 - 2024)

Novartis Ag's Amortization history runs 5 years deep, the most recent figure standing at $1.2 billion for Q4 2024.

• In Q4 2024, Amortization rose 7606.67% year-over-year to $1.2 billion; the TTM figure through Dec 2024 stood at $1.2 billion (up 7606.67% YoY), while the FY2024 annual figure was $1.2 billion, up 7606.67% from the prior year.
• Amortization came in at $1.2 billion for Q4 2024 at Novartis Ag, up from $419.0 million in the prior quarter.
• In the past five years, Amortization ranged from a high of $1.2 billion in Q4 2024 to a low of $15.0 million in Q4 2023.
• A 4-year average of $381.2 million and a median of $218.0 million in 2020 frame the typical range for Amortization.
• Across the five-year window, Amortization sank 55.05% in 2021 and soared 7606.67% in 2024, its largest moves.
• Novartis Ag's Amortization stood at $218.0 million in 2020, then tumbled by 55.05% to $98.0 million in 2021, then sank by 84.69% to $15.0 million in 2023, then jumped by 7606.67% to $1.2 billion in 2024.
• According to Business Quant data, Amortization over the past three periods registered $1.2 billion, $419.0 million, and $15.0 million for Q4 2024, Q2 2024, and Q4 2023 respectively.

Peer Comparison